Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 2 | -500K | 100% | $44.01 | -$22M |
Net | -2 | -500K | -100% | -$22M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Pontifax Management 4 G.P. (2015) Ltd. | 10%+ Owner | $55.5M | Nov 29, 2022 | ||
Jasbir Seehra | CHIEF EXECUTIVE OFFICER, Director | $11.5M | Feb 23, 2024 | ||
Orbimed Advisors Llc | Director | $5.26M | -$11M | -67.7% | Aug 13, 2024 |
Carl L. Gordon | Director | $5.26M | -$11M | -67.7% | Aug 13, 2024 |
Jennifer Lachey | Chief Scientific Officer | $4.31M | Jul 15, 2022 | ||
Jean Jacques Bienaime | Director | $9.06K | Jun 3, 2024 | ||
Mary Ann Gray | Director | May 30, 2024 | |||
Nima Farzan | Director | May 30, 2024 | |||
Julius Knowles | Director | May 30, 2024 | |||
Simon Peter Cooper | Chief Medical Officer | Feb 13, 2024 | |||
Keith Regnante | Chief Financial Officer | Feb 13, 2024 | |||
Ran Nussbaum | Director, 10%+ Owner | May 30, 2024 | |||
Yung H. Chyung | Chief Medical Officer | Nov 8, 2024 | |||
Alpna Seth | Director | May 30, 2024 | |||
Tomer Kariv | Director, 10%+ Owner | May 30, 2024 | |||
Claudia Ordonez | Chief Medical Officer | Jun 11, 2021 | |||
Christopher Rovaldi | Chief Operating Officer | Feb 13, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|